Log In
BCIQ
Print this Print this
 

CD34+ stem cell therapy

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionAutologous hematopoetic CD34+ stem cell therapy
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today